Dynavax Announces FDA Advisory Committee to Review HEPLISAV

Dynavax Technologies Corporation Tuesday announced that the U.S. Food and Drug Administration (FDA) has informed the Company that its Vaccines and Related Biological Products Advisory Committee (VRBPAC) is scheduled to discuss HEPLISAV at its meeting on November 14-15, 2012.
Yahoo! Finance